Startup profile for Authenticx: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker logo
Venture Capital Tracker

Startup profile · funding coverage

Authenticx funding, valuation and investors

Healthcare conversational intelligence — analyze customer call and interaction data at scale.

Verified company research · funding, investors and latest developments

Keep track of Authenticx

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$20M · January 2023

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$20M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · Indianapolis, IN

Investors in latest funding

Lead: Blue Heron Capital

Other: High Alpha , Elevate Ventures , Beringea , Allos Ventures

Sources: latest funding · prnewswire.com Last verified: 2026-07-26

Overview

Authenticx is an Indianapolis platform that helps healthcare organizations analyze customer conversations (calls and related interactions) for insights, quality, and experience improvement.

In January 2023 it announced a $20 million Series B led by Blue Heron Capital, with participation from Beringea, Indiana Next Level Fund/50 South Capital Advisors, High Alpha, Mutual Capital Partners, Signal Peak Ventures, Allos Ventures, Elevate Ventures, and M25. IBJ reported total funding around $28.8M since the 2018 launch. At announcement the company cited customers including five of the top 10 global pharmaceutical companies.

Why Authenticx is interesting

Indianapolis healthcare AI company that raised a $20M Series B (Jan 2023) led by Blue Heron Capital, with High Alpha and Elevate Ventures participating — listening layer for pharma and health call centers.

Product & use cases

Conversational intelligence software that mines healthcare customer interactions for themes, risk, and experience signals.

  • Pharma patient-support call analytics
  • Payer/provider contact-center quality programs
  • Compliance and experience monitoring from voice data

Key facts

  • Series B (Jan 2023): $20M led by Blue Heron Capital (PR Newswire)
  • Participants included High Alpha and Elevate Ventures
  • Cited five of top 10 global pharma as customers at raise
  • Total funding ~$28.8M per IBJ at announcement

Funding history (newest first)

Series B

2023-01 $20M

Source: Read source · prnewswire.com

Investors in our directory

Funds linked from Authenticx's profile — open a fund page for stage focus and related deal articles.

high-alpha elevate-ventures

Competitive landscape

Edge: Healthcare-specific conversational intelligence with Indy GTM and Series B growth capital.

  • CallMiner / NICE incumbent

    Enterprise conversation analytics.

  • Observe.AI adjacent

    AI contact-center platforms.

  • Qualtrics XM adjacent

    Broader experience management.

Industries

healthtech ai-ml enterprise-saas

Market / IPO context

Editorial / static context — not a live quote.

FAQs about Authenticx

Practical answers founders, operators, and investors typically search for.

Healthcare conversational intelligence — analyzing customer calls and interactions at scale.
Indianapolis, IN.
$20M in January 2023 led by Blue Heron Capital.
High Alpha and Elevate Ventures participated.
No — private as of July 2026.
series-b
Healthcare organizations — including large pharma contact centers — that need insight from customer conversations.
https://authenticx.com
Website All startups Funding news

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.